The levonorgestrel intrauterine system in the management of menorrhagia

British Journal of Obstetrics and Gynaecology
J W Barrington, Peter Bowen-Simpkins

Abstract

To assess the effect of a levonorgestrel releasing intrauterine system in the management of menorrhagia. A prospective study. A district general hospital in South Wales. Fifty women with a failed trial of medical therapy and awaiting hysterectomy or transcervical resection of the endometrium (TCRE) were treated with a levonorgestrel intrauterine system. The menstrual loss was estimated using a modified pictorial chart together with a full blood count and ferritin measurement preinsertion and at three and six to nine months postinsertion. The menstrual loss was reduced to acceptable levels in 37 women at three months and a further four by six to nine months. In all, 41 patients were taken off the waiting list for surgery, four of whom became amenorrhoeic. There was no significant change in full blood count nor ferritin measurement despite unscheduled bleeding for six to eight weeks postinsertion. Fifty-six percent of patients noticed considerable improvement or cure of their premenstrual syndrome symptoms; 80% noted a reduction in dysmenorrhoea. The levonorgestrel releasing intrauterine system is an effective nonsurgical treatment for the management of menorrhagia and dysmenorrhoea that has additional benefit as a contraceptive ...Continue Reading

References

Feb 1, 1992·British Journal of Obstetrics and Gynaecology·C P WestD T Baird
Aug 1, 1990·British Journal of Obstetrics and Gynaecology·J K Andersson, G Rybo
Aug 1, 1990·British Journal of Obstetrics and Gynaecology·J M HighamR W Shaw
Jul 1, 1989·British Journal of Obstetrics and Gynaecology·C J DockerayJ Bonnar
Feb 1, 1986·Contraception·T LuukkainenJ Toivonen

❮ Previous
Next ❯

Citations

Jun 8, 2001·Obstetrics and Gynecology·C F MaherC J Murray
Feb 24, 2001·BJOG : an International Journal of Obstetrics and Gynaecology·A StewartW Phillips
Apr 13, 2002·BJOG : an International Journal of Obstetrics and Gynaecology·Rani NagraniJulian W Barrington
Oct 18, 2002·Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology·P InkiJ Paavonen
Aug 19, 2000·Clinical Obstetrics and Gynecology·A P Korn
Feb 8, 2002·Obstetrical & Gynecological Survey·David Hubacher, David A Grimes
Sep 6, 2005·Current Opinion in Obstetrics & Gynecology·Lawrence L LinNarender N Bhatia
Apr 5, 2005·Clinical Obstetrics and Gynecology·Rameet H Singh, Paul Blumenthal
Sep 10, 1999·BMJ : British Medical Journal·C Kelleher, P Braude
Nov 24, 1999·BMJ : British Medical Journal·A Prentice
Apr 1, 2003·CNS Drugs·Torbjörn BäckströmDi Zhu
Jul 9, 2013·Journal of Mid-life Health·Osama ShawkiNavneet Magon
Sep 1, 2005·Women's Health·Regine Sitruk-Ware, Pirjo Inki
Jun 24, 2008·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·R K Bhathena, J Guillebaud
Jan 1, 1997·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·J W BarringtonP Bowen-Simpkins
Apr 3, 2013·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Lisa L Bayer, Paula J Adams Hillard
Oct 28, 2011·Gynécologie, obstétrique & fertilité·H GronierG Robin
Feb 7, 2009·Best Practice & Research. Clinical Obstetrics & Gynaecology·Zara Haider, Rachel D'Souza
Oct 31, 2008·Journal of Minimally Invasive Gynecology·Muzeyyen GunesMetin Kaplan
Jun 5, 2007·Best Practice & Research. Clinical Obstetrics & Gynaecology·Diana Mansour
May 29, 2007·Contraception·Rezan A Kadir, Claudia Chi
Feb 2, 2006·Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology·A HaberalO Ozdegirmenci
Jun 30, 2005·Best Practice & Research. Clinical Obstetrics & Gynaecology·Thomas F Baskett
Apr 2, 2016·Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC·Amanda BlackShireen Mansouri
May 30, 2006·Best Practice & Research. Clinical Obstetrics & Gynaecology·Ritva Hurskainen
Dec 6, 2005·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Rajesh VarmaJanesh K Gupta
Nov 24, 2004·The Journal of the American Association of Gynecologic Laparoscopists·Renato SeracchioliStefano Venturoli
Jan 8, 2008·American Journal of Obstetrics and Gynecology·SiHyun ChoByungSeok Lee
Feb 24, 2001·BJOG : an International Journal of Obstetrics and Gynaecology·C Kremer, S Duffy
Aug 6, 1998·British Journal of Obstetrics and Gynaecology·J Guillebaud
Jun 17, 2000·Obstetrics and Gynecology Clinics of North America·M G Munro
May 16, 2002·Haemophilia : the Official Journal of the World Federation of Hemophilia·J E Siegel, P A Kouides

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.